Floatz logo

Therapeutic Asset Ratings

6,299 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Eb-Dnk101 Dual-Targeting Car-Nk Cells
Pancreatic Ductal Adenocarcinoma
Beijing BiotechP1/2CC (44)
Eb-Nk-301
Cancer
Beijing BiotechP1/2CC (44)
ect204 t cells
Hepatocellular Carcinoma
Eureka Therapeutics Inc.P1/2CC (44)
Elranatamab
Hematopoietic And Lymphoid System Neoplasm
CellCentric Ltd.P1/2CC (44)
Enzalutamide
Endometrial Carcinoma
Cancer Research UKP1/2CC (44)
Epcoritamab
High-Grade B-Cell Lymphoma Double-Hit/Triple-Hit
Yazeed SawalhaP1/2CC (44)
Eras-007
Colorectal Cancer
Erasca, Inc.P1/2CC (44)
Fruquintinib
Hodgkins Lymphoma
Immunitas TherapeuticsP1/2CC (44)
Gedatolisib
Prostate Disorder
Celcuity IncP1/2CC (44)
Gilteritinib
Plasma Cell Myeloma
Sumitomo Pharma America, Inc.P1/2CC (44)
Gns 561
Hepatocellular Carcinoma
Genoscience PharmaP1/2CC (44)
gt201
Neoplasm
RenJi HospitalP1/2CC (44)
hcb101
Colorectal Cancer
Chang Gung Memorial HospitalP1/2CC (44)
Humanized Monoclonal Anti-Fgfr1 Antibody Om-Rca-01
Renal Cell Carcinoma
Kidney Cancer Research BureauP1/2CC (44)
Hypoestoxide
Parkinson Disease
University of IbadanP1/2CC (44)
Iadademstat
Lung Cancer
National Cancer Institute (NCI)P1/2CC (44)
Icasp9M28Z T Cell Infusions
Metastatic Neoplasm
Memorial Sloan Kettering Cancer CenterP1/2CC (44)
Ifebemtinib
Pancreatic Ductal Adenocarcinoma
InxMed (Shanghai) Co., Ltd.P1/2CC (44)
Immunoglobulin G1, Anti-(Human Interleukin-1 Receptor Accessory Protein) (Human-Mus Musculus Monoclonal Can04 .Gamma.1-Chain), Disulfide With Human-Mus Musculus Monoclonal Can04 .Kappa.-Chain, Dimer
Triple-Negative Breast Carcinoma
Cantargia ABP1/2CC (44)
Immunoglobulin H-Gamma1_L-Kappa, Anti-[Homo Sapiens Cd47 (Cd47 Molecule, Integrin Associated Protein, Iap, Mer6, Oa3) And Anti-[Homo Sapiens Dll3 (Delta-Like Ligand 3, Delta Like Canonical Notch Ligand 3)], Bispecific;
Large Cell Neuroendocrine Carcinoma
Phanes TherapeuticsP1/2CC (44)
Immunoglobulin H-Gamma1_L-Kappa, Anti-[Homo Sapiens Cd47 (Cd47 Molecule, Integrin Associated Protein, Iap, Mer6, Oa3) And Anti-[Homo Sapiens Dll3 (Delta-Like Ligand 3, Delta Like Canonical Notch Ligand 3)], Bispecific;
Prostate Neuroendocrine Neoplasm
Phanes TherapeuticsP1/2CC (44)
Immunoglobulin H-Gamma1_L-Kappa, Anti-[Homo Sapiens Cd47 (Cd47 Molecule, Integrin Associated Protein, Iap, Mer6, Oa3) And Anti-[Homo Sapiens Dll3 (Delta-Like Ligand 3, Delta Like Canonical Notch Ligand 3)], Bispecific;
Small Cell Lung Carcinoma
Phanes TherapeuticsP1/2CC (44)
Immunotherapic Bifunctional Fusion Protein Comprised Of A Fully Human Igg1 Monoclonal Antibody (Avelumab) Against Human Programmed Death-Ligand 1 (Pd-L1) Fused To The Soluble Extracellular Domain Of Transforming Growth Factor-.Beta. (Tgf-.Beta.) Receptor Ii, Which Acts As A Tgf-.Beta. Trap
Prostate Carcinoma
National Cancer Institute (NCI)P1/2CC (44)
Immunotherapic Bifunctional Fusion Protein Comprised Of A Fully Human Igg1 Monoclonal Antibody (Avelumab) Against Human Programmed Death-Ligand 1 (Pd-L1) Fused To The Soluble Extracellular Domain Of Transforming Growth Factor-.Beta. (Tgf-.Beta.) Receptor Ii, Which Acts As A Tgf-.Beta. Trap
Germ Cell Tumor
National Cancer Institute (NCI)P1/2CC (44)
Immunotherapic Bifunctional Fusion Protein Comprised Of A Fully Human Igg1 Monoclonal Antibody (Avelumab) Against Human Programmed Death-Ligand 1 (Pd-L1) Fused To The Soluble Extracellular Domain Of Transforming Growth Factor-.Beta. (Tgf-.Beta.) Receptor Ii, Which Acts As A Tgf-.Beta. Trap
Melanoma
National Cancer Institute (NCI)P1/2CC (44)
Showing 4001 to 4025 of 6,299 assets
PreviousPage 161 of 252Next